Multicenter study of human immunodeficiency virus-related germ cell tumors

Journal of Clinical Oncology

Volumn 21, Issue 10, 2003, Pages 1922-1927

  Powles, T ^a   Bower, Mark ^a   Daugaard, G ^a   Shamash, J ^a   De Ruiter, A ^a   Johnson, M ^a   Fisher, M ^a   Anderson, J ^a   Mandalia, S ^a   Stebbing, J ^a   Nelson, M ^a   Gazzard, B ^a   Oliver, T ^a  

^a Rigshospitalet

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; GERM CELL TUMOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; METASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; SEMINOMA; ADOLESCENT; CASE CONTROL STUDY; COHORT ANALYSIS; EUROPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SURVIVAL; TESTIS TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; EUROPE; GERMINOMA; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 0038350042     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.09.107     Document Type: Article

References (42)

1. Levine A: Non-Hodgkin's lymphomas and other malignancies in the acquired immune deficiency syndrome. Semin Oncol 14:34-39, 1987 (2 suppl 3)
2. Logothetis C, Newell G, Samuels M: Testicular cancer in homosexual men with cellular immune deficiency: Report of 2 cases. J Urol 133:484-486, 1985
3. Gabutti G, Vercelli M, De Rosa M, et al: AIDS related neoplasms in Genoa, Italy. Eur J Epidemiol 11:609-614, 1995
4. Lyter D, Bryant J, Thackeray R, et al: Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 13:2540-2546, 1995
5. Goedert J, Cote T, Virgo P, et al: Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839, 1998
6. Frisch M, Biggar R, Engels E, et al: Association of cancer with AIDS-related iinmunosuppression in adults. J Am Med Assoc 285:1736-1745, 2001
7. Bosl G, Motzer R: Testicular germ cell cancer. N Engl J Med 337:242-253, 1997
8. Oliver RT, Leahy M, Ong J: Combined seminoma/non-seminoma should be considered as intermediate grade germ cell cancer (GCC). Eur J Cancer 31A:1392-1394, 1995
9. Biggar RJ, Burnett W, Mikl J, et al: Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 43:979-985, 1989
10. Timmerman JM, Northfelt DW, Small EJ: Malignant germ cell tumors in men infected with the human immunodeficiency virus: Natural history and results of therapy. J Clin Oncol 13:1391-1397, 1995
11. Bernardi D, Salvioni R, Vaccher E, et al: Testicular germ cell tumors and human immunodeficiency virus infection: A report of 26 cases-Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13:2705-2711, 1995
12. Cooksley CD, Hwang LY, Waller DK, et al: HIV-related malignancies: Community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 10:795-802, 1999
13. Fizazi K, Amato RJ, Beuzeboc P, et al: Germ cell tumors in patients infected by the human immunodeficiency virus. Cancer 92:1460-1467, 2001
14. Grulich A, Li Y, McDonald A, et al: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16:1155-1161, 2002
15. Wilson WT, Frenkel E, Vuitch F, et al: Testicular tumors in men with human immunodeficiency virus. J Urol 147:1038-1040, 1992
16. Hentrich MU, Brack NG, Schmid P, et al: Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer 77:2109-2116, 1996
17. Straus DJ, Huang J, Testa MA, et al: Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142-Low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol 16:3601-3606, 1998
18. Tirelli U, Spina M, Sandri S, et al: Lung carcinoma in 36 patients with human immunodeficiency virus infection: The Italian Cooperative Group on AIDS and Tumors. Cancer 88:563-569, 2000
19. Fleming ID, Cooper JS, Henson DE, et al: AJCC Cancer Staging Manual (ed 5). New York, NY, Lippincott-Raven, 1997
20. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers-International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594-603, 1997
21. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
22. Weissbach L, Bussar-Maatz R, Mann K: The value of tumor markers in testicular seminomas: Results of a prospective multicenter study. Eur Urol 32:16-22, 1997
23. Nikzas D, Champion AE, Fox M: Germ cell tumours of testis: Prognostic factors and results. Eur Urol 18:242-247, 1990
24. Cesarman E, Chang Y, Moore PS, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191, 1995
25. Herndier BG, Kaplan LD, McGrath MS: Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049, 1994
26. Breese PL, Judson FN, Penley KA, et al: Anal human papillomavirus infection among homosexual and bisexual men: Prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22:7-14, 1995
27. Kaufman JJ, Bruce PT: Testicular atrophy following mumps. A cause of testis tumour? Br J Urol Int 35:67-69, 1963
28. Rajpert-De Meyts E, Hording U, Nielsen HW, et al: Human papillomavirus and Epstein-Barr virus in the etiology of testicular germ cell tumours. APMIS 102:38-42, 1994
29. Fend F, Hittmair A, Rogatsch H, et al: Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: Viral RNA transcripts (Epstein-Barr-encoded small RNAs) are present in intratumoral lymphocytes but absent from the neoplastic cells. Mod Pathol 8:622-625, 1995
30. Sauter M, Schommer S, Kremmer E, et al: Human endogenous retrovirus K10: Expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 69:414-421, 1995
31. Goedert JJ, Sauter ME, Jacobson LP, et al: High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS. Cancer Epidemiol Biomarkers Prev 8:293-296, 1999
32. Rapley EA, Crockford GP, Teare D, et al: Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 24:197-200, 2000
33. Torres A, Casanova JF, Nistal M, et al: Quantification of immunocompetent cells in testicular germ cell tumours. Histopathology 30:23-30, 1997
34. Nakanoma T, Nakamura K, Deguchi N, et al: Immunohistological analysis of tumour infiltrating lymphocytes in seminoma using monoclonal antibodies. Virchows Arch A Pathol Anat Histopathol 421:409-413, 1992
35. Parker C, Milosevic M, Panzarella T, et al: The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur J Cancer 38:2014-2019, 2002
36. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 338:853-860, 1998
37. Francis R, Bower M, Brunstrom G, et al: Surveillance for stage I testicular germ cell tumours: Results and cost benefit analysis of management options. Eur J Cancer 36:1925-1932, 2000
38. Hakim FT, Cepeda R, Kaimei S, et al: Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-3798, 1997
39. Powles T, Imami N, Nelson M, et al: Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 16:531-536, 2002
40. Santin AD, Hermonat PL, Ravaggi A, et al: Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 48:997-1006, 2000
41. Warde P, Gospodarowicz MK, Panzarella T, et al: Long term outcome and cost in the management of stage I testicular seminoma. Can J Urol 7:967-972, 2000
42. Flechon A, Culine S, Droz JP: Intensive and timely chemotherapy, the key of success in testicular cancer. Crit Rev Oncol Hematol 37:35-46, 2001